Scanned, public-record documents relating to administrative actions.
Our vision is to be the premier consumer protection agency by leading and partnering in the effort to prevent harm and advance high quality, safe medical care.
Latest News
SACRAMENTO - Last week, the Members of the Medical Board of California (Board) elected Kristina D. Lawson, J.D., to continue serving as Board president. In addition, Board members chose Dr. James M. Healzer, M.D., to be the Board's vice president, and Dr. Michelle Anne Bholat, M.D., MPH, as Board secretary. Lawson has served as Board President since May 2024, and previously from November 2020 to August 2023. Dr. Healzer was previously the Board's Secretary.
Beginning August 1, 2024, all California dispensers of controlled substances will be required to report dispensations to the Controlled Substance Utilization Review and Evaluation System (CURES) using the American Society of Automation in Pharmacy (ASAP) version 4.2B format. Licensees who dispense controlled substances should contact their data submission software provider to confirm they are prepared for this version update. Please visit the Office of the Attorney General's CURES Website to access the Data Submission guide for Dispensers and for additional updates and informational bulletins.
For information about CURES, visit DCA's CURES information page.
Medical Board of California Seeks Stakeholder Input Regarding Mental and Physical Health Questions on Licensing Applications
7/3/2024
The Medical Board of California (Board) will be holding an interested parties meeting via WebEx on Tuesday, July 30, 2024, between 10:00 a.m. – 12:00 p.m., to hear from speakers and receive feedback on whether the Board should change its introductory statement and/or questions relating to mental and physical health on its licensing applications, which currently state:
An affirmative answer to any of the questions below will not automatically disqualify you from licensure. The Board will make an individualized assessment of the nature, the severity and the duration of the risks associated with an ongoing medical condition to determine whether an unrestricted license should be issued, whether conditions should be imposed, or whether you are eligible for licensure. Please note that a limited practice license may be available.
- Are you currently enrolled in, or participating in any drug, alcohol, or substance abuse recovery program or impaired practitioner program?
- Do you currently have any condition (including, but not limited to emotional, mental, neurological or other physical, addictive, or behavioral disorder) that impairs your ability to practice medicine safely?
- Do you currently have any other condition that impairs or limits your ability to practice medicine safely?
If any interested party has comments on this matter, please submit them in writing to impairment-questions@mbc.ca.gov no later than Friday, July 19, 2024.
In addition, there will be a public comment period during the interested parties meeting on July 30, 2024. An agenda that includes instructions regarding how to participate in the meeting will be published on the Board’s website and distributed no later than 10 days prior to the meeting. To receive the agenda, please subscribe to the “Board and Committee Meetings” email alert.